New Delhi, March 11 || The government has issued a draft Gazette Notification proposing amendments to avoid duplicate viral testing of blood products and invited public comments on it, an official statement said on Wednesday.
The amendment aims to align regulatory requirements for testing of blood products with internationally accepted pharmacopeial standards and to remove additional testing requirements on products that are not warranted under global best practices, the Ministry of Health and Family Welfare said in the statement.
The amendments were proposed to "Para G (Testing of Blood Products), Part XII C, Schedule F of the Drugs Rules 1945".
The ministry described the move as a step toward regulatory harmonisation, scientific rationalisation of testing requirements and reduction of avoidable compliance burden while continuing to uphold patient safety.